ABVC BioPharma's total assets for Q2 2025 were $16.24M, an increase of 9.18% from the previous quarter. ABVC total liabilities were $6.75M for the fiscal quarter, a -2.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.